Trial
NCT01451853
SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Sound Pharmaceuticals, Incorporated
Collaborators
VA Puget Sound Health Care System
Condition
Lung Cancer
Intervention
SPI-1005 Low Dose
Why stopped
Study did not start
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-03